American Water's Christine Keck Appointed to Washington Post Intelligence Council
Get Alerts AWK Hot Sheet
Join SI Premium – FREE
Keck Brings Industry Expertise to Leading Policy Advisory Group
"We're thrilled that Christine has joined WP Intelligence's Council on Energy & Climate, and look forward to having her contribute to our world class thought leadership programs and briefings around the world," said
WP Intelligence is The Washington Post's newest suite of services providing senior executives with the insights and connections they need to navigate critical issues. This unique offering, which operates independently from The Post's newsroom, also encompasses invitation-only membership Councils in the fields of AI & Tech, Health Care, Energy & Climate and Global Security.
"I am honored to join the WP Intelligence Council and collaborate with such a talented network of professionals across multiple industries," said Keck. "Together, we can create real change and encourage innovation across many areas—but what matters most to me is championing policies and advancements that help enable safe, clean, reliable and affordable water services for future generations."
With more than two decades of leadership in utility management and public affairs, Keck's appointment underscores American Water's commitment to shaping the future of water stewardship across the
Keck's first convening as a member of the Council took place at the Global Women's Summit in late November in
About American Water
American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in
For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram.
View original content to download multimedia:https://www.prnewswire.com/news-releases/american-waters-christine-keck-appointed-to-washington-post-intelligence-council-302629203.html
SOURCE American Water
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
- FLSmidth: Transactions under share buy-back programme
- Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share